Estradiol And Norethindrone Acetate NDC 79929-012

NDC codes

FDA NDC Directory

Product NDC (as listed)79929-012Labeler and product segments. Claims need a package NDC.

Product NDC at billing width79929-0012Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
79929-012-07	79929001207	84 BLISTER PACK in 1 POUCH (79929-012-07) / 28 TABLET in 1 BLISTER PACKMarketed from Jun 11, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Estradiol And Norethindrone Acetate
Generic name (nonproprietary): estradiol and norethindrone acetate
Active ingredients: Norethindrone acetate — .5 mg/1Estradiol — 1 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Naari Pte. Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210233
Marketing start: Jun 11, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Estradiol Congeners (Chemical structure)Estrogen Receptor Agonists (Mechanism)Progesterone Congeners (Chemical structure)
Identifiers: Product ID 79929-012_1a990fcf-1731-8ca1-e063-6294a90ac9c8SPL ID 1a990fcf-1731-8ca1-e063-6294a90ac9c8SPL set ID f70185fe-9fcf-655f-e053-6394a90a20dcRxCUI 1359126, 1359127UNII 9S44LIC7OJ, 4TI98Z838EUPC 0379929012075
Pharmacologic class: Estrogen; Progestin

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N479929001207 followed by a unit qualifier and the quantity

Package 79929-0012-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 11, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

Estradiol and Norethindrone acetate tablets is indicated for: Estradiol and Norethindrone acetate tablet is an estrogen and progestin combination indicated in a woman with a uterus for: • Treatment of Moderate to Severe Vasomotor Symptoms due to Menopause (1.1) • Treatment of Moderate to Severe Symptoms of Vulvar and Vaginal Atrophy due to Menopause (1.2) Limitations of Use: When prescribing solely for the treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause, first consider the use of topical vaginal products. • Prevention of Postmenopausal Osteoporosis (1.3) Limitations of Use: When prescribing solely for the prevention of postmenopausal osteoporosis, firs…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)